TIVICAY is a prescription HIV-1 medicine that is used with other antiretroviral medicines to treat Human Immunodeficiency Virus-1 (HIV-1) infection. HIV-1 is the virus that causes (AIDS).
If eligible, you will receive savings up to $6000 per year for medicines
containing dolutegravir [TIVICAY® (dolutegravir) and TRIUMEQ® (abacavir,
dolutegravir, and lamivudine)].